FDA approves pralsetinib for lung cancer with RET gene fusions
The Food and Drug Administration granted accelerated approval to pralsetinib for adult patients with metastatic…
Browsing: Oncomine Dx Target
The Food and Drug Administration granted accelerated approval to pralsetinib for adult patients with metastatic…